Company Filing History:
Years Active: 1998-2000
Title: The Innovations of Ronald Fj De Winter
Introduction
Ronald Fj De Winter is a notable inventor based in Milton Ernest, GB. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antibodies. With a total of 2 patents, his work has implications for cancer diagnosis and treatment.
Latest Patents
De Winter's latest patents focus on murine/human chimeric monoclonal antibodies that exhibit high specificity and affinity for human carcinoembryonic antigen (CEA). These inventions include processes for the preparation of these antibodies and their derivatives, as well as the DNAs coding for the heavy and light chains of these antibodies. The chimeric antibodies and their derivatives are designed for clinical applications both in vitro and in vivo. They are particularly useful for cancer diagnosis, localization, and in vivo imaging of tumors. Additionally, these inventions encompass test kits and pharmaceutical compositions that contain the chimeric monoclonal antibodies and their derivatives.
Career Highlights
Ronald Fj De Winter is associated with Ciba-Geigy Corporation, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in medical technology and therapeutic applications.
Collaborations
Some of his notable coworkers include Norman Hardman and Laura Lee Gill. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field.
Conclusion
Ronald Fj De Winter's contributions to the field of biotechnology through his patents on chimeric antibodies highlight his role as a significant inventor. His work continues to impact cancer diagnosis and treatment, showcasing the importance of innovation in healthcare.